Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Total-Cash-From-Operating-Activities" stands at 17.06 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 3.75 Billion EUR for the item "Total Cash From Operating Activities" represents an increase of 5.49 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 3.75 Billion EUR for the item "Total Cash From Operating Activities" represents a decrease of -2.55 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 17.06 Billion EUR for the item "Total Cash From Operating Activities" represents a decrease of -0.57 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 41.50 percent compared to the value the year prior.
The 1 year change in percent is 41.50.
The 3 year change in percent is 77.80.
The 5 year change in percent is 100.87.
The 10 year change in percent is 91.21.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cash From Operating Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cash From Operating Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cash From Operating Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cash From Operating Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cash From Operating Activities | 280,205,508,085.11 |